NCT02243813View on ClinicalTrials.gov

Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Healthy
Interventions
DRUG

Psilocybin

Participants will receive 20 mg/70 kg of psilocybin in the first session and will receive either 20 or 30 mg/70 kg in the second session.

Trial Locations (1)

21224

Behavioral Biology Research Center, Johns Hopkins Bayview, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02243813 - Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion | Biotech Hunter | Biotech Hunter